We are live on ! Find out more
IVC

Invacare Corporation

Delisted

IVC was delisted on the 31st of January, 2023.

83 hedge funds and large institutions have $26.3M invested in Invacare Corporation in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 34 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% less funds holding

Funds holding: 10983 (-26)

25% less call options, than puts

Call options by funds: $82K | Put options by funds: $110K

28% less capital invested

Capital invested by funds: $36.6M → $26.3M (-$10.2M)

32% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 34

70% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 33

Holders
83
Holders Change
-26
Holders Change %
-23.85%
% of All Funds
1.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
23
Reduced
34
Closed
33
Calls
$82K
Puts
$110K
Net Calls
-$28K
Net Calls Change
+$49K
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
Rutabaga Capital Management
Massachusetts
$2.4M +$56.6K +43,000 +2%
Renaissance Technologies
2
Renaissance Technologies
New York
$2.31M -$146K -110,956 -6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.03M -$186K -140,992 -8%
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$1.78M
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$1.45M +$277K +209,895 +23%
Charles Schwab
6
Charles Schwab
California
$1.3M +$897K +681,212 +203%
Morgan Stanley
7
Morgan Stanley
New York
$1.28M +$258K +195,966 +24%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$1.21M -$553K -420,120 -31%
Franklin Resources
9
Franklin Resources
California
$1.08M -$2.55K -1,938 -0.2%
BlackRock
10
BlackRock
New York
$978K -$2.01M -1,529,236 -67%
AGAM
11
Audent Global Asset Management
California
$878K +$904K +686,275 New
Two Sigma Advisers
12
Two Sigma Advisers
New York
$833K -$30.7K -23,300 -3%
Nomura Holdings
13
Nomura Holdings
Japan
$771K -$248K -188,007 -24%
AQR Capital Management
14
AQR Capital Management
Connecticut
$735K +$229K +173,592 +43%
NRC
15
North Run Capital
Massachusetts
$587K -$614K -465,770 -50%
Two Sigma Investments
16
Two Sigma Investments
New York
$582K -$303K -229,772 -34%
First Manhattan
17
First Manhattan
New York
$569K +$586K +445,000 New
Millennium Management
18
Millennium Management
New York
$566K +$137K +103,627 +31%
Invesco
19
Invesco
Georgia
$520K +$89.4K +67,889 +20%
PCMI
20
Paradigm Capital Management Inc
New York
$448K +$329K +250,000 +250%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$388K -$396K -300,420 -50%
JP Morgan Chase
22
JP Morgan Chase
New York
$295K -$284K -215,790 -48%
BCM
23
Bridgeway Capital Management
Texas
$250K -$33.9K -25,754 -12%
E
24
Ergoteles
New York
$208K +$214K +162,500 New
AWS
25
Atria Wealth Solutions
New York
$205K +$145K +110,001 +220%

IVC Hedge Fund Activity: Q2 2022 in Review

83 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Invacare Corporation (IVC) for Q2 2022, worth a combined $26.3M — down 28% from $36.6M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of IVC and 10 opened new positions — a net loss of 23 holders — while 34 trimmed existing stakes and 23 added.

The largest buyer was Audent Global Asset Management, opening a new position worth an estimated $904K. The largest seller was BlackRock, cutting an estimated $2.01M.

  • 83 institutional investors held Invacare Corporation (IVC) as of Q2 2022, down from 109 in Q1 2022.
  • Funds reported $26.3M of Invacare Corporation stock for Q2 2022, down 28% quarter-over-quarter.
  • 10 funds opened new Invacare Corporation positions in Q2 2022 and 33 closed out, a net change of -23 holders.
  • The largest Invacare Corporation buyer in Q2 2022 was Audent Global Asset Management, an estimated $904K added.
  • The largest Invacare Corporation seller in Q2 2022 was BlackRock, an estimated $2.01M sold.

Based on aggregated 13F filings for Q2 2022.